Form 4: Director Mily Acquires Solventum Stock via RSU Vesting

Solventum Corp Director Elizabeth Mily acquired 1,980 shares of common stock through the vesting of restricted stock units on March 27, 2026.

Summary

• Elizabeth Mily, a Director of Solventum Corp (SOLV), acquired 1,980 shares of common stock.
• The acquisition occurred on March 27, 2026, through the settlement of fully vested Restricted Stock Units (RSUs).
• Each RSU represented a contingent right to receive one share of common stock, with an acquisition price of $0 per share.
• Following this transaction, Elizabeth Mily beneficially owns 5,606 shares of Solventum Corp common stock directly.
• A Limited Power of Attorney, executed on March 6, 2026, authorizes Megan Bombick and Kristen Brown to prepare and file Section 16 reports on behalf of Elizabeth Mily.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it's a routine vesting, it increases a director's direct ownership, which generally signals continued alignment with shareholder interests.

Positives

• The transaction increases Director Elizabeth Mily's direct beneficial ownership in Solventum Corp, aligning her interests further with shareholders.
• The vesting of RSUs is a standard compensation practice, indicating the fulfillment of previously established equity incentive plans.

Future Outlook

This Form 4 reports a historical insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to equity compensation such as RSU vesting, are common occurrences in publicly traded companies. This filing reflects a routine event for a director receiving shares as part of their compensation package, rather than a discretionary open-market purchase or sale.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor positive impact due to increased director ownership, which can be seen as a sign of confidence and alignment with shareholder interests.

Next Steps

• Elizabeth Mily will continue to be subject to Section 16 reporting obligations for her holdings and transactions in Solventum Corporation securities.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction resulting from the vesting of restricted stock units, not a discretionary open-market purchase or sale. While it increases the director's direct holdings, it does not provide new fundamental information about the company's operational or financial performance to warrant a change in investment recommendation. Investors should consider this a standard compensation event.

Keywords

Solventum, SOLV, Elizabeth Mily, Form 4, insider transaction, stock acquisition, RSU, restricted stock units, director, beneficial ownership